The pathogenetic role of 5α-reductase isoenzymes in androgenetic alopecia;Die pathogenetische bedeutung der 5α-reduktase-isoenzyme fur die androgenetische alopezie

Hautarzt

Volumn 50, Issue 3, 1999, Pages 165-173

  Hoffmann, R ^a   Happle, R ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NONE

Author keywords

5 reductase; Androgens; Dihydrotestosterone; Hair; Hair loss

Indexed keywords

STEROID 5ALPHA REDUCTASE;

ALOPECIA; ANDROGEN SYNTHESIS; ENZYME ACTIVITY; GERMANY; HUMAN; PATHOGENESIS; REVIEW;

EID: 0032941301     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050884     Document Type: Review

References (71)

1. Andersson S, Bishop RW, Russell DW (1989) Expression, cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Cell Biol 264:16249-16255
2. Andersson S, Berman EM, Jenkins EP, Russel DW (1990) Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354:159-161
3. Andersson S, Russell DW (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci 87:3640-3644
4. Bayne EK, Flanagan J, Azzolina B, Einstein M, Mumford R, Ayala J, Chang B, Thiboutot D, Singer II, Harris G (1997) Immunolocalization of type II 5α-reductase in human hair follicles. J Invest Dermatol 108:651
5. Bergfeld WF (1995) Androgenetic alopecia: an autosomal dominant disorder. Am J Med 98:995-985
6. Braun-Falco O, BergnerT (1989) Die androgenetische Alopezie des Mannes. Hautarzt 40:669-678
7. Beckmann MW, Wieacker P, Dereser MM, Flecken U, Breckwoldt M (1993) Influence of steroid hormones on 5α-reductase activity in female and male genital skin fibroblasts in culture. Acta Endocrinol 128:161-167
8. Boudon C, Lobaccaro JM, Lumbroso S, Ögur G, Öcal G, Belon C, Sultan C (1995) A new deletion of the 5α-reductase type 2 gene in a Turkish family with 5α-reductase deficiency. Clin Endocrinol 43:183-188
9. Chen W, Zouboulis CC, Orfanos CE (1996)The 5α-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 193:177-184
10. Chen W, Zouboulis CC, Fritsch M, Blume-Peytavi U, Kodelja V, Goerdt S, Luu-The V, Orfanos CE (1998) Evidence of heterogeneity and quantitative differences of the type 1 5α-reductase expression in cultured human skin cells -evidence of its presence in melanocytes. J Invest Dermatol 110:84-89
11. Courchay G, Boyera N, Bernard BA, Mahe Y (1996) Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacol 9:169-172
12. Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK (1994) The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 79:703-706
13. Drews U (1995) Morphologische Entwicklung der Sexualorgane. Gynäkologe 28:5-11
14. Dykstra KD, Payne M, Abdelrahim M, Francis GL (1993) Insulin-like growth factor-1, but not growth hormone, has in vitro proliferative effects on neonatal foreskin fibroblasts without affecting 5α-reductase or androgen receptor activity. J Androl 14:73-78
15. Ebling FJG (1992) Functions of the skin. In: Champion RH, Burton JL, Ebling FJG (eds) Textbook of dermatology. Blackwell, Oxford, pp 125-155
16. Eicheler W, Dreher M, Hoffmann R, Happle R, Aumüller G (1995) Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 133:371-376
17. Eicheler W, Huth A, Happle R, Hoffmann R (1996) RNA-levels of 5α-reductase and androgen receptor in human skin, hair follicles and follicle-derived cells. In: vanNeste D, Randall VA (eds) Hair research for the next milennium. Elsevier, Amsterdam, pp 327-331
18. Eicheler W, Happle R, Hoffmann R (1998) 5α-reductase activity in the human hair follicle concentrates in the dermal papilla. Arch Derm Res 290:126-132
19. Ellis JA, Stebbing M, Harrap SB (1998) Genetic analysis of male pattern baldness and the 5α-reductase genes. J Invest Dermatol 110:849-853
20. Ellsworth K, Azzolina B, Baginski W, Bull K, Chang B, Cimis G, Mitra S, Toney J, Bakshi RK, Rasmusson GH, Tolman RL, Harris GS (1996) MK-386: a potent, selective inhibitor of the human type I 5α-reductase. J Steroid Biochem Molec Biol 58:377-384
21. Fazekas AG, Lanthier A (1971) Metabolism of androgens by isolated human beard hair follicles. Steroids 18:367-379
22. Francz PI, Bayreuther K, Limat A, Noser F (1992) Differentiation and polypeptide expression in human papilla and dermal fibroblasts in vitro. Eur J Cell Biol 60:337-345
23. George FW, Russell DW, Wilson JD (1991) Feed-forward control of prostate growth: Dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase. Proc Natl Acad Sci 88:8044-8047
24. Gerdes MJ, Dang TD, Lu B, Larsen M, McBride L, Rowley DR (1996) Androgen-regulated proliferation and gene transcription in a prostate smooth muscle cell line (PS-1). Endocrinology 137:864-872
25. Hamilton JB (1942) Male hormone stimulation is prerequisite and an incitement in common baldness. Am J Anat 71:451-455
26. Hirsch KS, Jones CD, Audia JE, Andersson S, McQuaid L, Stamm NB, Neubauer BL, Pennington P, Toomey RE (1993) LY 191704: A selective, non-steroidal inhibitor of human steroid 5α-reductase type I. Proc Natl Acad Sci (USA) 90:5277-5281
27. Hoffmann R, Wenzel E, Eicheler W, Happle R (1997) Microdissected dermal papillae versus cultured dermal papilla cells: Different gene expression ex vivo and in vitro. J Invest Dermatol 107:942
28. Hoffmann R, Happle R (1998) Finasteride is the main inhibitor of 5α-reductase activity in microdissected dermal papillae from human hair follicles. J Invest Dermatol 110:529 (Abstr)
29. Horton R, Pasupuletti V, Antonipillai I (1993) Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-1. Endocrinology 133:447-451
30. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE (1974) Steroid 5α-reductase-deficiency in man: an inherited form of male pseudohermaphroditism. Science 186:1213-1215
31. Imperato-McGinley J, Binienda Z, Arthur A, Minenberg D, Vaughan ED, Quimby F (1986) The development of male pseudohermaphoditic rat using an inhibitor of the enzyme 5α-reductase. Endocrinol 113:569-573
32. Itami S, Kurata S, Takayasu S (1991a) 5α-reductase activity in cultured human dermal papilla cells in beard compared with reticular fibroblasts. J Invest Dermatol 94:150-152
33. Itami S, Kurata S, Sonoda T, Takayasu S (1991b) Characterization of 5α-reductase in cultured human dermal papilla cells from beard and occipital scalp hair. J Invest Dermatol 96:57-60
34. Jahoda CAB, Home KA, Oliver RF (1984) Induction of hair growth by implantation of cultured dermal papilla cells. Nature 311:560-562
35. Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW (1992) Genetic and pharmacologic evidence for more than one human steroid 5α-reductase. J Clin Invest 89:293-300
36. Kaufman K (1996) Androgen metabolism as it affects hair growth in androgenetic alopecia. Derm Clin 14:697-711
37. Kaufman K (1998) Treatment of men with androgenetic alopecia with finasteride: the 2-year experience. Lecture at the international meeting "Clinical dermatology 2000", 18-20 June 1998, Singapore
38. Küster W, Happle R (1984) The inheritance of common baldness: two B or not two B? J Am Acad Dermatol 11:921-926
39. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ (1991) Clinical and biochemical parameters of androgen action in normal healthy caucasian versus chinese subjects. J Clin Endocrinol Metab 72:1242-1248
40. Mahendroo MS, Cala KM, Landrum DP, Russell DW (1997) Fetal death in mice lacking 5 alpha-reductase type 1 caused by estrogen excess. Mol Endocrinol 11:917-927
41. Matias JR, Malloy V, Orentreich N (1989) Animal models of androgen-dependent disorders of the pilosebaceous apparatus. Arch Derm Res 281:247-253
42. Mellin TN, Busch RD, Rasmusson GH (1993) Azasteroids as inhibitors of testosterone 5α-reductase in mammalian skin. J Steroid Biochem Molec Biol 44:121-131
43. Mestayer CH, Berthaut I, Portois MC, Wright F, Kuttenn F, Mowszowicz I, Mauvais-Jarvis P (1996) Predominant expression of 5α-reductase type 1 in pubic skin from normal subjects and hirsute patients. J Clin Endocrinol Metabol 81:1989-1993
44. Metcalf BW, Levy MA, Holt DA (1989) Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne. TIPS Rev 10:491-495
45. Moore RJ, Wilson JD (1974) Steroid 5α-reductase activity in cultured human fibroblasts: biochemical and genetic evidence for two distinct enzyme activities. J Biol Chem 251:5895-5900
46. Neumann F (1995) Endokrinologie der Geschlechtsentwicklung. Gynäkologe 28:12-16
47. Nitsche EM, Moquin A, Adams PS, Guenette RS, Lakins JN, Sinnecker GHG, Kruse K, Tenniswood L (1996) Differential display RT PCR of total RNA from human foreskin fibroblasts for investigation of androgen-dependent gene expression. Am J Med Gen 63:231-238
48. Osborn D (1916) Inheritance of baldness. J Hered 7:347-355
49. Randall VA, Thornton MJ, Messenger AG (1992) Cultured dermal papilla cells from androgen-dependent human follicles (e.g. beard) contain more androgen receptors than those from non-balding areas. J Endocrinol 133:141-147
50. Rhodes L, Primka R, Berman C, Gato G, Audette-Arruda J, Pikounis B, Matuszewska B, Harper J (1994) Effects of 1 year treatment with oral MK386, an inhibitor of type 1 5α-reductase, in the stumptailed macaque (macaca arctoides). J Clin Endocrinol Metab 79:991-996
51. Rittmaster RS, Uno H, Povar ML, Mellin TN, Loriaux DL (1987) The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5αlpha-androstane-17beta-carboxa-mide, a 5α-reduc-tase inhibitor and anti-androgen, on the development of baldness in the stumptail macaque. J Clin Endocrinol Metab 65:188-193
52. Salamon T (1968) Genetic factors in male pattern alopecia. In: Baccaredda-Boy A, Moretti G, Frey JR (eds) Biopathology of pattern alopecia. Karger, Basel New York, pp 39-49
53. Sawaya ME, Price VH (1997) Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109:296-300
54. Salle Di E, Giudici D, Biagini L, Cominato C, Briatico G, Panzeri A (1995) Effects of 5 alpha-reductase inhibitors on intraprostatic androgens in the rat. J Steroid Biochem Mol Biol 53:381-385
55. Salle Di E, Briatico G, Giudici D, Ornati G, Panzeri AE (1994) Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073). J Steroid Biochem Mol Biol 48:241-248
56. Schmidt JA, Schweikert HU (1986) Testosterone and epitestosteron meta-bolism of single hairs in 5 patients with 5α-reductase deficiency. Acta Endocinol 113:588-592
57. Schwartz JI, van Hecken A, de Schepper PJ, de Lepeleire I, Lasseter C, Shamblen EC, Winchell GA, Constanzer ML, Chavez CM, Wang DZ, Ebel DL, Justice SJ, Gertz BJ (1996) Effect of MK-386, a novel inhibitor of type 1 5α-reductase, alone and in combination with finasteride on serum dihydrotestosterone concentrations in men. J Clin Endocrinol Metab 81:2942-2947
58. Schwartz JI, Laskin OL, Meeter CA, Patterson PM, Schneider SH, Lasseter KC, Seibold JR (1994) Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrations. Clin Pharmacol Ther 55:50-54
59. Schweikert HU, Wilson JD (1974a) Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab 38:811-819
60. Schweikert HU, Wilson JD (1974b) Regulation of human hair growth by steroid hormones. I. Androstenedione metabolism in isolated hairs. J Clin Endocrinol Metab 39:1012-1019
61. Schweikert HU (1995) Intersexualität: Gonadendysgenesien und testikuläre Feminisierung. Gynäkologe 28:17-26
62. Siiteri PK, Wilson JD (1974) Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 38:113-125
63. Sonoda T, Kurata S, Asada Y, Takayasu S (1998) Message of protease nexin-1 is expressed in human dermal papilla cells and is affected by androgens. J Invest Dermatol 100:612 (Abstr)
64. Takayasu S, Wakimoto H, Itami S, Adachi K (1972) The conversion of testosterone to 17ß-hydroxy-5α-androstan-3-one (DHT) by human hair follicles. J Clin Endocrinol Metab 34:1098-1101
65. Thiboutot DM, Knaggs H, Gilliland K, Hagari S (1997) Activity of 5α-reductase type I is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 136:166-171
66. Thipgen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russel DW (1992) Molecular genetics of steroid 5α-reductase 2 deficiency. J Clin Invest 90:799-809
67. Thornton MJ, Laing I, Hamada K, Messenger AG, Randall VA (1993) Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Clin Endocinol 39:633-639
68. Sreekumar GP, Pardinas J, Wong CQ, Whiting D, Katz I, Price V, Zolotogovski A, Roberts J, Stenn K, Parimoo S (1998) Search for male pattern baldness gene(s): Hormone and chromosome 2 and 5 linkage analysis. J Invest Dermatol 110:622
69. Van Scott EJ, Ekel TM (1958) Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp. J Invest Dermatol 31:281-287
70. Vermorken AJM, Goos CMAA, Roelofs HMJ (1980) A method for the evaluation of the local antiandrogenic action of 5α-reductase inhibitors on human skin. Br J Dermatol 102:695-701
71. Whigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New Ml, Wilson JD, Russel DW (1994) Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry 33:1265-1270